Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
about
Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.Photodynamic therapy for cholangiocarcinomaPhotodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma.Photodynamic therapy for cholangiocarcinoma.Systematic review: photodynamic therapy for unresectable cholangiocarcinoma.Current status of photodynamic therapy for bile duct cancer.Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma.Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction.Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis.Photodynamic therapy for unresectable cholangiocarcinoma.Endoscopic treatment options for cholangiocarcinomas.Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin.Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
P2860
Q28080850-189AF23F-8523-4105-95AB-723A21EDE46FQ28252343-FF177FC7-21CD-45B9-8D01-A72FE54F2A90Q30433853-5E466043-5EB6-477D-9185-FDD6771D5AB3Q30434108-F985E708-2576-46A5-8D02-8025B13C5665Q33448593-1993AA7C-6DA2-4509-A573-C8F8AADAED0BQ34592228-35EEDE59-A306-4AF2-8A30-BDE362506E4DQ35959699-27FCAC14-C806-4B74-8616-A4F98EB15B46Q36020107-B88E1BEB-0C49-454B-B020-D84708A1AF5CQ37578491-6226904D-8AC6-4E88-BBBF-1491B719A3C6Q37662645-201DA36C-1D45-454F-A415-698A5F991BC9Q37953210-284F04D9-229B-4C08-9BE5-CD548AACF1B2Q38186132-5AA9AB7A-57F9-4FF8-97FD-5B1C372D9C7BQ42267989-A6321E53-4BD8-4886-8A2D-35B47482B45BQ46106876-6808080B-E82E-4FDD-ADBE-02A34C4CEFB8
P2860
Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Factors associated with increa ...... herapy for cholangiocarcinoma.
@ast
Factors associated with increa ...... herapy for cholangiocarcinoma.
@en
Factors associated with increa ...... herapy for cholangiocarcinoma.
@nl
type
label
Factors associated with increa ...... herapy for cholangiocarcinoma.
@ast
Factors associated with increa ...... herapy for cholangiocarcinoma.
@en
Factors associated with increa ...... herapy for cholangiocarcinoma.
@nl
prefLabel
Factors associated with increa ...... herapy for cholangiocarcinoma.
@ast
Factors associated with increa ...... herapy for cholangiocarcinoma.
@en
Factors associated with increa ...... herapy for cholangiocarcinoma.
@nl
P2093
P1476
Factors associated with increa ...... herapy for cholangiocarcinoma.
@en
P2093
Andrew J LeRoy
Ganapathy A Prasad
Kenneth K Wang
Lori S Lutzke
Louis-Michel Wongkeesong
Lynn S Borkenhagen
Navtej S Buttar
P304
P356
10.1016/J.CGH.2007.02.021
P407
P577
2007-06-01T00:00:00Z